iShares U.S. Consumer Focused ETF (IEDI)
Live price chart, market sentiment, and community perspectives for iShares U.S. Consumer Focused ETF (CBOE: IEDI).
Live price chart, market sentiment, and community perspectives for iShares U.S. Consumer Focused ETF (CBOE: IEDI).
On our desk, the major talking point isn't just the 23.78x portfolio P/E or the modest discount to the benchmark's 26.20x valuation—it's the sudden June 2026 supplement revealing that the Board of Trustees approved the complete closure and liquidation of IEDI. With creation and redemption units ceasing after market close on August 12, 2026, and trading halting before the bell on August 13, all strategic positioning needs to pivot toward managing cash payout logistics for the August 17 liquidation date.
Looking at the quantitative risk profile, IEDI historically showed resilience with a 5-year beta of 0.99 and a 5-year max drawdown of -27.6%, which outperformed the broader Consumer Cyclical category average of -34.9%. However, recent metrics told a different story, including a 3-year downside capture of 114 and technical positioning sitting below both the 50-day moving average of $56.29 and the 200-day moving average of $55.86, pointing to persistent macro friction from goods inflation and tight monetary policy.
When evaluating how to talk about consumer-focused equity products in current market interviews, I emphasize IEDI's unique structural paradox. While Morningstar historically awarded it 4 stars and a low long-horizon return rank versus its category, the underlying discretionary exposure was heavily constrained by persistent consumer budget adjustments under a 4.25% to 4.50% Fed rate environment, ultimately culminating in the fund's shutdown rather than organic asset growth.
From a market sentiment perspective, quantitative desks noted neutral prevailing sentiment alongside conflicting short-term setups—ranging from algorithmic short signals targeting a 3.3% to 3.6% downside to consolidation channels near the $55.25 handle. With the official SEC supplement confirming liquidation proceeds are scheduled for distribution on or around August 17, 2026, any lingering debate over short-term technical oscillators has been entirely superseded by the hard operational timeline.
Our risk management framework highlights that despite boasting a 3-year Sharpe ratio of 0.50—which sat above the category median of 0.33—long-term holders faced a Morningstar return-versus-category rating of 'Low'. Combined with tariff-driven goods price pressures throughout 2025 and 2026 forcing discretionary pullback, the fund's risk-reward profile failed to secure sustained institutional asset retention.
Explore plasma cleansing, somatic organ swaps, and BCI.